Janus Henderson Investors US’s Nektar Therapeutics NKTR Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change %
Capital Flow Portfolio Weight Portfolio Position
2017
Q1
$40.1M Sell
113,982
-5,241
-4% -$1.84M 0.03% 488
2016
Q4
$21.9M Sell
119,223
-3,879
-3% -$714K 0.02% 597
2016
Q3
$31.7M Sell
123,102
-15,018
-11% -$3.87M 0.03% 517
2016
Q2
$29.5M Sell
138,120
-7,133
-5% -$1.52M 0.03% 509
2016
Q1
$30M Sell
145,253
-12,695
-8% -$2.62M 0.03% 508
2015
Q4
$39.9M Buy
157,948
+4,845
+3% +$1.22M 0.03% 492
2015
Q3
$25.2M Buy
153,103
+32,323
+27% +$5.31M 0.02% 558
2015
Q2
$22.7M Buy
120,780
+21,545
+22% +$4.04M 0.02% 587
2015
Q1
$16.4M Buy
99,235
+15,042
+18% +$2.48M 0.01% 648
2014
Q4
$19.6M Buy
84,193
+5,456
+7% +$1.27M 0.02% 607
2014
Q3
$14.3M Buy
78,737
+10,540
+15% +$1.91M 0.01% 637
2014
Q2
$13.1M Sell
68,197
-5,865
-8% -$1.13M 0.01% 624
2014
Q1
$13.5M Buy
74,062
+11,504
+18% +$2.09M 0.01% 616
2013
Q4
$10.7M Sell
62,558
-6,251
-9% -$1.06M 0.01% 656
2013
Q3
$10.8M Sell
68,809
-20,403
-23% -$3.2M 0.01% 637
2013
Q2
$15.5M Buy
+89,212
New +$15.5M 0.02% 547